… The first reports of the use of allogeneic umbilical cord stem cells in a patient with COVID-19 …
The therapy was carried out on a 65-year-old patient with respiratory failure and COVID-19 …

… that stem cell therapy can be, at least, a complementary therapy to alleviate sufferings in
COVID-19 … This review discusses the possible therapeutic uses of MSCs for treating COVID-19. …

… The present study focuses on stem cell characteristics and … the effect of stem cell-based
strategies for COVID-19 treatment … “stem cell biology,” “immunomodulatory effects of stem cells,” …

… The aim of this review is to examine studies of the clinical efficacy and safety of mesenchymal
stem cell therapy in ARDS resulting from COVID-19 infection. Studies were reviewed in …

… Current registered clinical trials are primarily focused on the use of stem cells obtained
from allogenic sources such as donated Wharton's jelly or umbilical cord tissues (Tables 1–3). …

… COVID-19 disease causes damage to hematopoietic stem/progenitor cells (HSPCs) and
endothelial progenitor cells (… Additionally, SARS-CoV-2 directly infects erythroid progenitor cells, …

… are on the international clinical research registration website (clinicaltrials.gov), and most
of the application projects are focused on the target population for critical COVID-19 patients. …

… at a very high rate by causing COVID-19 disease. Nearly 507 … drugs and vaccines versus
the COVID-19 pandemic, new … of mesenchymal stem cells (MSCs) in a subgroup of COVID-19 …

… role in abating the severity of COVID-19. This review … Stem Cells (MSCs) based therapy
alone or in combination with other therapeutics as an attractive curative approach for COVID-19 …

… the application of stem cells to manage COVID-19, and also a … the application of stem cells
to treat COVID-19. Even though data … focus on the use of multiple infusions of high numbers of …